Injective Extends US and European Reach Amid Weak INJ Momentum
Injective is expanding market access through a Nasdaq-listed staked INJ product and MiCA disclosures as the token trades near $7.
Injective is expanding market access through a Nasdaq-listed staked INJ product and MiCA disclosures as the token trades near $7. Injective (INJ) is trading at ₹662 ($7.05), up 0.7% since this brief published. This is an original Token Times brief based on reporting by TronWeekly, with live market data added, as of Tue, 17 Nov 2026 02:45:02 UTC.
The initiatives could broaden institutional participation and improve regulatory positioning in two major markets, although INJ’s recent decline shows that access gains have not yet translated into positive near-term price momentum.
- Injective is expanding access to US and European markets
- A Nasdaq-listed staked INJ product supports institutional engagement
- MiCA disclosures add a European regulatory compliance layer
- INJ is $7, down 13.78% over seven days
TronWeekly reports that
Injective is expanding its presence in the United States and Europe through two developments: a Nasdaq-listed product providing staked INJ exposure and regulatory disclosures prepared under the Markets in Crypto-Assets framework, or MiCA.
The source says these measures could improve institutional access and support wider ecosystem adoption. The staked product offers a listed route to participate in INJ-related activity, while the MiCA disclosures address regulatory visibility for European market engagement.
According to TronWeekly, analyst TurboBull identifies $12.50 and $16 as potential upside targets for INJ. Those levels are analyst targets rather than confirmed outcomes, and the report does not provide a separate methodology or timeframe for them.
INJ last traded at $7, essentially unchanged over 24 hours but down 13.78% over seven days, with a market capitalization of $698.98 million. The broader crypto market was flat at $2.27 trillion,
Bitcoin gained 0.53% over 24 hours, and the Fear & Greed index stood at 10, labelled Extreme Fear. The forthcoming focus is whether access and compliance initiatives gain measurable adoption while the token remains well below the cited analyst levels.
Since this brief published about 32 hours ago, Injective (INJ) has moved from ₹657.72$7.00 to ₹662.42$7.05 — +0.71%.
The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 INJ ≈ ₹687.41 (about $7.05), up 2.0% over 24 hours. The rupee itself trades about 3.8% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
Figures and sectors in this story, checked live against on-chain aggregators · November 15, 2026.
Token Times reads these figures directly from on-chain aggregators (DeFiLlama, mempool.space) at build time — independent of what any outlet reported. Sector totals aggregate every protocol DeFiLlama tracks in that category. Values are live and will change.
Injective Extends US and European Reach Amid Weak INJ Moment — questions & answers
How is Injective expanding access to US and European markets?
TronWeekly cites a Nasdaq-listed staked INJ product and MiCA regulatory disclosures as the two expansion initiatives.
What upside levels does TurboBull identify for INJ?
The analyst identifies $12.50 and $16 as potential upside targets. TronWeekly provides no timeframe or supporting methodology.
How is INJ performing against the broader market?
INJ is $7, down 13.78% over seven days and nearly flat over 24 hours. Bitcoin rose 0.53% over the same 24-hour period.
How much is 1 Injective worth in rupee today?
About ₹687.41 at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $7.05. The rupee price moves with both INJ's US-dollar price and the USDT/INR rate; use our Injective in rupee page for any amount.
Has Injective's price moved since this brief was published?
INJ is up 0.71% since this brief first published — trading at ₹662 ($7.05) now versus ₹658 ($7.00) at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from TronWeekly. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.